Serious infections in patients with rheumatoid arthritis

被引：0
|
作者：
Maerker-Hermann, E. [1 ]
Nitschmann, S. [1 ]
机构：
[1] HELIOS Dr Horst Schmidt Kliniken Wiesbaden, Klin Immunol & Nephrol, Klin Innere Med 4, Rheumatol, Ludwig Erhard Str 100, D-65199 Wiesbaden, Germany
来源：
INTERNIST | 2016年 / 57卷 / 03期
关键词：
D O I：
10.1007/s00108-015-0012-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：298 / 300
页数：3
相关论文
共 50 条
  • [31] Risk factors of serious infections in patients with rheumatoid arthritis treated with tocilizumab in the French Registry REGATE
    Morel, Jacques
    Constantin, Arnaud
    Baron, Gabriel
    Dernis, Emmanuelle
    Flipo, Rene Marc
    Rist, Stephanie
    Combe, Bernard
    Gottenberg, Jacques Eric
    Schaeverbeke, Thierry
    Soubrier, Martin
    Vittecoq, Olivier
    Dougados, Maxime
    Saraux, Alain
    Mariette, Xavier
    Ravaud, Philippe
    Sibilia, Jean
    RHEUMATOLOGY, 2017, 56 (10) : 1746 - 1754
  • [32] Predictors of serious infections in rheumatoid arthritis-a prospective Brazilian cohort
    de Almeida, Ana Luisa Bagno
    Guimaraes, Maria Fernanda B. Resende
    Pinto, Maria Raquel da Costa
    Pereira, Leticia Rocha
    Reis, Ana Paula Monteiro Gomides
    Bonfiglioli, Karina Rossi
    Louzada-Junior, Paulo
    Giorgi, Rina Dalva Neubarth
    de Castro, Glaucio Ricardo Werner
    Radominski, Sebastiao Cezar
    Brenol, Claiton Viegas
    Pugliesi, Alisson
    da Mota, Licia Maria Henrique
    Castelar-Pinheiro, Geraldo da Rocha
    ADVANCES IN RHEUMATOLOGY, 2024, 64 (01)
  • [33] The Risk Of Serious Infections In Patients Receiving Rituximab For Rheumatoid Arthritis: Results From The British Society For Rheumatology Biologics Register-Rheumatoid Arthritis
    Silva-Fernandez, Lucia
    Lunt, Mark
    Low, Audrey S.
    Watson, Kath D.
    Symmons, Deborah P.
    Hyrich, Kimme L.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S341 - S341
  • [34] Serious infections in rheumatoid arthritis. What is the scope of the problem.
    Ramey, DR
    Rausch, PL
    Schettler, JD
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S279 - S279
  • [35] THE RISK FACTORS OF SERIOUS INFECTION IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Hasegawa, E.
    Kobayashi, D.
    Ito, S.
    Narita, I.
    Nakazono, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1061 - 1061
  • [36] Serious infections under treatment with TNF-α antagonists compared to traditional DMARDs in patients with rheumatoid arthritis
    N. Inanc
    H. Direskeneli
    Rheumatology International, 2006, 27 : 67 - 71
  • [37] Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor α antagonists
    Curtis, Jeffrey R.
    Patkar, Nivedita
    Xie, Aiyuan
    Martin, Carolyn
    Allison, Jeroan J.
    Saag, Michael
    Shatin, Deborah
    Saag, Kenneth G.
    ARTHRITIS AND RHEUMATISM, 2007, 56 (04): : 1125 - 1133
  • [38] Frailty Is Associated with Serious Infections in Biologic and Targeted-synthetic DMARD Treated Patients with Rheumatoid Arthritis
    Singh, Namrata
    Gold, Laura
    Wysham, Katherine
    Andrews, James
    Reid, Pankti
    Makris, Una
    England, Bryant
    Lee, Jiha
    George, Michael
    Baker, Joshua
    Jarvik, Jeffrey
    Heagerty, Patrick
    Singh, Siddharth
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4404 - 4406
  • [39] Co-morbidities increase the risk of serious infections in patients with rheumatoid arthritis treated with TNFα inhibitors
    Davas, Evangelos M.
    Alexiou, Ioannis
    Boulbou, Mary
    Koutroumpas, Athanasios
    Makaritsis, Konstantinos
    Stathakis, Nikolaos
    Sakkas, Lazaros I.
    JOURNAL OF INFECTION, 2008, 57 (05) : 418 - 420
  • [40] Serious infections under treatment with TNF-α antagonists compared to traditional DMARDs in patients with rheumatoid arthritis
    Inanc, N.
    Direskeneli, H.
    RHEUMATOLOGY INTERNATIONAL, 2006, 27 (01) : 67 - 71
12345